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Key points
• Malignant Hyperthermia (MH) affects the Ca2+ movements that control muscle contraction.
We measured Ca2+ movements in skeletal muscle of “Y522S” mice, with a tyrosine-to-serine
mutation in the RyR channel that causes MH in mice and humans.
• In YS cells, [Ca2+] inside the Ca2+ store (sarcoplasmic reticulum, SR) was 45% of that in the
wild type (WT), but the SR membrane permeability increased 2-fold, resulting in Ca2+ release
of initially normal value.
• During Ca2+release, cytosolic [Ca2+] and SR Ca2+ buffering power evolved differently in YS and
WT. These variables became similar in WT exposed to BAPTA, an inhibitor of Ca2+-dependent
inactivation (CDI) of the RyR, suggesting that tyrosine 522 is involved in CDI.
• Similar paradoxical observations in YS and WT cells with reduced content of the SR protein
calsequestrin, revealed the importance of balance between SR Ca permeability (increased in
YS) and storage capability (decreased when calsequestrin is low).
Abstract Malignant hyperthermia (MH) is linked to mutations in the type 1 ryanodine receptor,
RyR1, the Ca2+ channel of the sarcoplasmic reticulum (SR) of skeletal muscle. The Y522S MH
mutation was studied for its complex presentation, which includes structurally and functionally
altered cell ‘cores’. Imaging cytosolic and intra-SR [Ca2+] in muscle cells of heterozygous YS
mice we determined Ca2+ release flux activated by clamp depolarization, permeability (P) of
the SR membrane (ratio of flux and [Ca2+] gradient) and SR Ca2+ buffering power (B). In
YS cells resting [Ca2+]SR was 45% of the value in normal littermates (WT). P was more than
doubled, so that initial flux was normal. Measuring [Ca2+]SR(t) revealed dynamic changes in
B(t). The alterations were similar to those caused by cytosolic BAPTA, which promotes release by
hampering Ca2+-dependent inactivation (CDI). The [Ca2+] transients showed abnormal ‘breaks’,
decaying phases after an initial rise, traced to a collapse in flux and P. Similar breaks occurred in
WT myofibres with calsequestrin reduced by siRNA; calsequestrin content, however, was normal
in YS muscle. Thus, the Y522S mutation causes greater openness of the RyR1, lowers resting
[Ca2+]SR and alters SR Ca2+ buffering in a way that copies the functional instability observed
upon reduction of calsequestrin content. The similarities with the effects of BAPTA suggest that
the mutation, occurring near the cytosolic vestibule of the channel, reduces CDI as one of its
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primary effects. The unstable SR buffering, mimicked by silencing of calsequestrin, may help
precipitate the loss of Ca2+ control that defines a fulminant MH event.
(Resubmitted 30 May 2013; accepted after revision 24 June 2013; first published online 24 June 2013)
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Introduction
Excitation–contraction coupling involves a finely
controlled sequence of rapid Ca2+ movements that start
with Ca2+ release from the sarcoplasmic reticulum (SR)
and then involves every organelle in the muscle cell.
These movements are controlled by at least five proteins
(DHPR dihydropiridine receptor, RyR, triadin, junctin
and calsequestrin) that constitute a physically connected
chain, which we call the couplon (a term introduced by
Stern et al. 1997, referring initially to the voltage sensors
and calcium release channels on one side of a skeletal
muscle triad). Alterations of the skeletal muscle couplon
at various levels, including mutations of the DHPR (Eltit
et al. 2012), the RyR (MacLennan & Zvaritch, 2011),
and deletion of calsequestrin (as reviewed by Protasi
et al. 2011), may result in malignant hyperthermia (MH:
MIM no. 145600), a subclinical disorder characterized
by a fulminant and potentially lethal hypermetabolic
reaction to inhalational anaesthetics and succinylcholine
(MacLennan & Zvaritch, 2011).
Strikingly parallel is the situation in cardiac muscle,
given the linkage of many mutations in ryanodine receptor
2 (RyR2), a few in calsequestrin 2 (Priori & Chen, 2011)
and at least one in triadin (Roux-Buisson et al. 2012) with
catecholaminergic polymorphic ventricular tachycardia
(CPVT), a potentially lethal dysrhythmia, analogous to
MH in producing uncontrolled events of Ca2+ release
(Priori & Chen, 2011). These associations, valid for both
types of striated muscle, promote a unifying view of
pathogenesis, showing that similar syndromes may arise
from defects in different members of the chain of proteins
that control Ca2+ release.
Seventy per cent of the cases of MH have defects
in the ryanodine receptor 1 gene RyR1, and some 300
mutations of RyR1 have been linked to MH and/or the
related central core disease (CCD). Similarly, nearly 200
mutations in RyR2 are linked to CPVT. Among these
mutations, many are concentrated in highly conserved
regions or ‘hotspots’, largely homologous in RyR1 and
RyR2. While the identification and further study of
these mutants is primarily driven by the need to under-
stand and prevent or alleviate the associated diseases, the
study of the well-defined functional defects associated
with each mutation is becoming a useful approach to
unravel structure–function relationships in these large and
complex channels.
Several mice have been created with RyR1 mutations
homologous to those associated with MH in humans
(Yang et al. 2006; Chelu et al. 2006; Yuen et al. 2012).
All show a MH-like hypermetabolic response to volatile
anaesthetics and temperature. Among them, the Y524S
mice (Y522S in humans) appear to be the most sensitive
to temperature since they usually do not survive more than
15 min at 37◦C (Lanner et al. 2012). The multi-systemic
nature of the hypermetabolic response to temperature in
the Y524S mice has suggested that they are also models of
enhanced susceptibility to heat stroke (Durham et al. 2008;
Lanner et al. 2012). In humans the Y522S mutation is also
associated with central cores and the Y524S mice develop
metabolically inactive cores as they age (Boncompagni
et al. 2009). Tyrosine 522 is part of the N-terminal domain
(‘hotspot 1’, MacLennan & Zvaritch, 2011) containing a
large number of amino acids that are known to be mutated
in human MH and CCD. This domain of RyR1 was recently
crystallized (Tung et al. 2010) and localized by docking in
3-D cryo-electron microscopy structures (e.g. Samsó et al.
2005).
New insight into the disease processes has been obtained
from studies of the YS mice (Durham et al. 2008;
Andronache et al. 2009; Boncompagni et al. 2009; Lanner
et al. 2012) and other mouse models of malignant hyper-
thermia (Estéve et al. 2010; Feng et al. 2011; Yuen et al.
2012) and CCD (Zvaritch et al. 2007). Here we apply
recently developed techniques to further evaluate the
fundamental changes in Ca2+ handling that are caused
by the Y524S mutation. The main technical advance is the
direct determination of [Ca2+]SR, which takes advantage
of the highly specific location of the SR-targeted biosensor
D4cpv-calsequestrin (Sztretye et al. 2011a). Combining
this measurement with the determination of Ca2+ release
flux and amount of released Ca2+, we can for the first time
evaluate the permeability of the releasing SR membrane
(P, a direct measure of the openness, popen, of the release
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channels), and Ca2+ buffering power, B, of the SR.
[Ca2+]SR, P and B proved to be drastically changed in
the YS mutant. Much of the change can be explained if
one of the primary consequences of the mutation is the
partial or total loss of the susceptibility of the channel to
inactivation by cytosolic Ca2+.
Methods
Construction of silencing vectors
The oligonucleotide encoding the specific small inter-
fering (si)RNA for Casq1 was inserted into pSilencer-1.0
vector (Ambion, Austin, TX, USA) downstream of the
U6 promoter using ApaI and EcoRI sites as described pre-
viously (Wang et al. 2006). To produce fluorescent markers
of transfection, enhanced cyan fluorescent protein (ECFP)
or enhanced yellow fluorescent protein (EYFP) expression
cassettes were inserted downstream of the multiple cloning
region at the NotI site using standard procedures. Initially,
the enhanced green fluorescent protein (EGFP) cassette
from the vector pCMS-EGFP (Clontech Laboratories,
Mountain View, CA, USA) was amplified by PCR and
inserted into the NotI site of pSilencer-1.0. Subsequently,
the EGFP coding region was removed and replaced by the
one of ECFP or EYFP using the AgeI and BclI restriction
sites. The vectors pECFP-N1 and pEYFP-N1 (Clontech
Laboratories) were used as PCR templates.
Immunoblotting
Two slightly different techniques were used for Western
blots with different purposes. To compare calsequestrin
(Casq) content in Y522S and wild-type muscles, whole
soleus, extensor digitorum longus (EDL) and diaphragm
muscles from six wild-type (WT) and six Y524S mice were
homogenized and lysed in 4◦C radioimmunoprecipitation
assay (RIPA) buffer with phosphatase and protease
inhibitors, consisting of (mM): 25 Tris, 150 NaCl, 1
Na3VO4, 10 NaPyroPO4, 10 β-glycerophosphate, 10 NaF,
phenylmethylsulfonyl fluoride (PMSF) protease inhibitor
cocktail (Santa Cruz Biotechnology, Dallas, TX, USA),
1% NP40, 1% sodium deoxycholate, and 0.1% sodium
dodecyl sulfate. pH was 7.6. Total protein concentration
was measured using the BCA protein assay (Thermo
Scientific). Equal amounts of total protein from whole
muscle lysates were resolved by electrophoresis and
then transferred to polyvinylidene difluoride (PVDF)
membrane for Western blot analysis. Calsequestrin
was identified using anti-calsequestrin 1 antibody
MA3-913 (Affinity Bioreagents) at 1:1000 dilution.
Glyceraldehyde-3-phosphate dehydrogenase (GADPH;
with antibody sc-20357, Santa Cruz Biotechnology, at
1:500 dilution) was used as a control for homogeneous
total protein loading. LI-COR IRDye infrared dyes were
used as secondary antibodies and immunoreactive bands
were visualized using the Odyssey Infrared Imaging System
(LI-COR Biosciences).
For evaluation of Casq1 gene silencing in individual
flexor digitorum brevis (FDB) muscles, an entire FDB
muscle was homogenized at 4◦C in RIPA buffer. Total
protein concentration was measured using a modified
version of the Lowry method (DC Protein Assay;
BioRad, Lincoln, NE, USA). Proteins were separated
electrophoretically using the SDS-PAGE buffer system.
After separation the proteins were transferred electro-
phoretically to a nitrocellulose membrane and stained
for calsequestrin 1 and GAPDH as described above. The
protein bands were detected using a chemiluminescent
substrate (Super Signal West Dura; Thermoscientific) and
horseradish peroxidase-conjugated secondary antibodies.
Transgenic animals
Fourteen mice heterozygous for the Y522S mutation and
10 WT littermates, produced as described by Chelu et al.
(2006) were used in these experiments. The animals were
raised in Baylor College of Medicine, and studied at Rush
University, at 7–15 weeks of age.
Transfection of FDB muscles in adult mice
and isolation of single cells
Some of the results reported here were obtained by
analysis of data collected in an earlier study of permeability
(Sztretye et al. 2011b). In most cases muscles were made
to express the biosensor D4cpv-Casq1 (Sztretye et al.
2011a,b). The method of transfection and cell separation
was described by Sztretye et al. (2011a). Experiments were
performed 4–5 days after injection of plasmid at 20–22◦C
in ‘External’ solution.
Ethical approval and killing
Protocols for animal care, transfection and killing were
approved by the Institutional Animal Care and Use
Committee of Rush University, which found them
consistent with their ethical standards. Mice (6–14 weeks),
of weight between 25 and 37 g, were killed by inhalation
of a rising concentration of CO2.
Solutions
‘RIPA buffer’ (mM): 150 NaCl, 10 Tris, 5 EDTA. pH
was adjusted to 7.2 with HCl. ‘External’ solution (mM):
140 TEA-CH3SO3, 1 CaCl2, 3.5 MgCl2, 10 Hepes,
1 4-aminopyridine, 0.5 CdCl2, 0.3 LaCl3, 0.001 TTX
(citrate), 0.05 N-benzyl-p-toluene sulphonamide (BTS).
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pH was adjusted to 7.2 with TEA-OH and osmolality to
320 mosmol kg−1 with TEA methanesulfonate.
Internal solutions (in pipette) were either ‘EGTA’ or
‘BAPTA’. ‘EGTA’ (mM): 110 N-methylglucamine, 110 L-
glutamic acid, 10 EGTA, 10 Tris, 10 glucose, 5 Na ATP,
5 phosphocreatine Tris, 0.075 X-rhod 1, 3.56 CaCl2 and
7.4 MgCl2. ‘BAPTA’ (mM): 120 potassium L-glutamate, 5
BAPTA, 10 Trizma, 5 Na ATP, 5 phosphocreatine Tris,
5.4 CaCl2, 7.19 MgCl2, 10 glucose. pH was set to 7.2
with NaOH and osmolality to 320 mosmol kg−1 with
N-methylglucamine. The amounts of added Ca2+ and
Mg2+ were calculated as in Manno et al. (2013).
Voltage clamp
The whole-cell patch clamp technique follows the
implementation of Wang et al. (1999), with changes
described by Royer et al. (2008). The clamped cells were
stable in ‘BAPTA’, as ascertained by the stability of series
resistance, linear capacitance (Cm), charging time constant
and holding current. The actual recording of Ca2+ trans-
ients was started after 15–35 min of stable holding at
−80 mV, a time when the concentration of EGTA or
BAPTA inside the cell was at a substantial fraction of
the solution values (as was described previously, Manno
et al. 2013). Non-linear capacitive (‘charge movement’)
currents obtained by conventional subtraction of scaled
controls and baseline correction were integrated to
calculate intramembranous charge transfers QON and
QOFF as functions of V m. The dependence QON(V m) was
fitted with the ‘Boltzmann’ function: Q ON = Q max/(1 −
eVm−V̄/K ) to derive the amount of mobile charge Qmax,
transition voltage V̄, and limiting logarithmic slope 1/K .
The mean values of these parameters were not statistically
significantly different from those recorded in our pre-
vious work with this technique (Royer et al. 2008,
2010).
Simultaneous measurement of cytosolic and
SR-lumenal [Ca2+] using a biosensor
In the experiments reported here Ca2+ transients and
release flux are examined in parallel with [Ca2+]SR
largely as described by Sztretye et al. (2011b). Every cell
studied expressed D4cpv-Casq1 or D4cpv-δAsp in the
SR; they were voltage clamped and had the high affinity,
long wavelength Ca2+ monitor X-rhod 1 introduced
in the cytosol via the patch pipette. Images Fj(x, t)
were obtained in line scan mode. F1 and F2 represent
fluorescence of D4cpv-Casq1 and D4cpv-δAsp, and F3 of
X-rhod 1. The images were acquired in a laser scanning
confocal system (SP2, Leica Microsystems, Exton, PA,
USA) equipped with acousto-optical tunable elements
that allowed excitation of X-rhod 1 (at 594 nm, with
emission collected between 610 and 700 nm) alternating
line-by-line with the excitation for D4cpv (at 458 nm, with
emission collected between 470 and 510 nm for F1, and
between 520 and 580 nm for F2); therefore images were
effectively simultaneous. At the acquisition frequencies
used, the alternate illumination resulted in actual intervals
of 2.5–10 ms per line (5 ms per line in most cases) in the
individual images. Spatial resolution was 0.24 μm pixel−1.
Line scanning was always parallel to the fibre axis, at
10–15 μm from the glass coverslip.
After averaging Fj(x, t) over x, to obtain Fj(t), the
‘FRET ratio’ R was calculated as (F2 – Background2)/(F1
– Background1). Backgroundi was measured with lasers
off. [Ca2+]SR was calculated from the ratio by a
generalization of the equilibrium equation (Sztretye et al.
2011a)
[Ca2+] = βK D R − Rmin







× Rmax − Rmin
[Rmax − R + β(R − Rmin)] (Rmax − R)
(1)
where β is the ratio of values of F1 in the Ca2+-free and
the Ca2+-saturated conditions. The parameter values of
Rmin (0.505), Rmax (1.74), βK D (222 μM) and β (0.554)
were determined in calibrations in situ (Sztretye et al.
2011a). kon was assumed to be 3.6 × 106 M−1 s−1 (the value
determined in solution at room temperature for cameleon
D1, Palmer et al. 2004).
Determination of free cytosolic [Ca2+]
Average cytosolic [Ca2+], [Ca2+]c(t), is calculated from
averaged X-rhod fluorescence F(t) as
[Ca2+]c (t) = (F − F min) kOFF + dF/dt
(F max − F ) kON (2)
Fmax and Fmin are derived from eqn (2) applied to
the resting condition, in which [Ca2+]c(0) ≡ [Ca2+]R
is assumed equal to that in the pipette (0.1 μM, an
assumption based on previous results, Royer et al. 2010).
Equation 2 then becomes 0.1 μM = (F − Fmin)K D/(Fmax
− F). Other parameter values are given in Sztretye et al.
(2011a).
Release flux and permeability
Ca2+ release flux Ṙ(t) was derived from [Ca2+]c(t) by
the removal method (Melzer et al. 1987; Schuhmeier
& Melzer, 2004; Royer et al. 2008), which involves
assigning parameter values in a model of the removal of
released Ca2+, so that the simulation fits the observed
decay of cytosolic Ca2+ simultaneously for several evoked
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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transients. Permeability was calculated as
P (t) = Ṙ/ ([Ca2+]SR(t) − [Ca2+]c(t)) ≈ Ṙ/[Ca2+]SR(t)
(3)
The removal method, if strictly applied, yields Ṙ(t)
records of reliable kinetics but unreliable scale (details in
Manno et al. 2013). [Dye]total, [EGTA]total and [BAPTA]total
were set proportionally to the concentrations in the pipette
and an exponential ‘entry’ function of time (Royer et al.
2010).
The kinetic constants of EGTA:Ca were kON =
15 (μM s)−1 and kOFF = 7.5 s−1 (Schuhmeier & Melzer,
2004; Royer et al. 2008). For BAPTA:Ca they were
kON = 1000 (μM s)−1 and kOFF = 200 s−1 (Wu et al.
1996). Parvalbumin concentration was set to 1 mM. Its
rate constants with Ca2+ were set as kON = 100 (μM s)−1
and kOFF = 1 s−1; for Mg2+ kON = 0.03 (μM s)−1 and kOFF =
3 s−1. kuptake, the proportionality constant linking the rate
of pump removal to [Ca2+]c, was allowed to vary among
cells for the best fit of [Ca2+]c(t). The best fit kuptake varied
in the range 3.5–20 ms−1.
Amount released
The net flux leaving the SR, Ṙnet(t), is derived by sub-
traction of the pump removal flux from Ṙ(t), the flux that
exits through release channels,
Ṙnet(t) = Ṙ(t) − kuptake[Ca2+]c(t) (4)
The integral of Ṙnet, from the beginning of the pulse





Because the images were acquired at low frequencies,
the peak of release flux was blunted. This effect was
corrected, for the purpose of tabulating peak values,
using empirical factors derived as described by Royer
et al. (2008). The more slowly varying flux during the
so-called quasi-steady phase that follows the peak during
a long-lasting depolarization can be measured equally well
at different acquisition rates and needs no correction (as
shown by Royer et al. 2008).
SR Ca2+ buffering power
B is defined as d[Ca]T,SR/d[Ca2+]SR, a derivative of total
with respect to free Ca2+ concentration in the SR. Because
the change in total concentration is derived from the
release flux, which is expressed relative to the volume of
aqueous solution in the cytosol, a factor is necessary to







× 0.7 l of cytosol/l of cell
0.055 l of SR/l of cell
]
= d[Ca]T, SR/d[Ca2+]SR × 12.7 (6)
The adjustment factor, 12.7 (Manno et al. 2013), is the
ratio of cytosolic volume (0.7 of cell volume) to SR
volume (0.055). The values of B averaged during the
pulse and afterwards will be represented as BON and BOFF,
respectively; formally:
B ON = [Ca]T,SR/[Ca2+]SR × 12.7 during the ON and
B OFF = [Ca]T,SR/[Ca2+]SR × 12.7 during the OFF.
(7)
Supplemental material
Supplemental material is available online only.
Supplemental Tables S1 and S2 present average parameters
of voltage dependence of activation of Ca2+ release
and intramembranous charge displacement in YS cells.
Table S3 presents average parameters of intramembranous
charge displacement in Casq1-silenced cells. Figure S1
and associated narrative illustrates the reproducibility
of [Ca2+]SR transients. Figure S2 provides an additional
example of the changes in P and B recorded in YS cells.
Results
MH events are essentially catastrophic alterations of
Ca2+ management in skeletal myofibres. To learn more
about Ca2+ management in cells of mice carrying the
Y522S mutation in their RyR1 we combined established
techniques for dynamic measurement of cytosolic [Ca2+]
transients and the underlying Ca2+ release flux with the
newly available measurement of [Ca2+]SR(t) (Sztretye
et al. 2011a). Combined, these measurements yield two
functionally important variables: the permeability, P(t),
of the Ca2+-releasing SR membrane (Sztretye et al. 2011b;
calculated by eqn (3)) and B(t), the Ca2+ buffering power
of the SR (Manno et al. 2013; calculated by eqns (6)
and (7)). This was done for Ca2+ release evoked by
depolarizing pulses in plasma membrane voltage (V m),
pulses that were of high amplitude so that the V m
sensors would be put in a fully activating configuration,
and long-lasting, to cause deep depletion in the store
and explore its consequences. But before engaging in
these measurements it was important to establish the
V m dependence of activation by repeating an earlier
determination by Andronache et al. (2009). Our purpose
C© 2013 The Authors. The Journal of Physiology C© 2013 The Physiological Society
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was to test whether a consequential property of this
dependence, observed in their work, applied in our setting.
Vm dependence of Ca2+ release flux and
intramembranous charge movement are
negatively shifted in the mutant
Andronache et al. (2009) observed a similar shift in the V m
dependence, by about 8 mV in the negative direction, of
both flux and movement of the intramembranous voltage
sensor in the YS mutant cells. As in the earlier study, we
imaged Ca2+ transients and measured intramembranous
charge movement during pulses to variable voltages in
cells from YS mutants and their WT littermates. The V m
dependence of peak flux and charge displacement was
fitted with descriptive sigmoidal functions, with mean
best-fit parameters listed in Supplemental Tables S1 and
S2. We fully confirm results of the earlier work: the V m
of half-release activation, V r, shifted negatively in the YS,
by about 5 mV on average. Also as found in the previous
study, the mid-voltage V̄ of the ‘Boltzmann’ fit to the intra-
membranous charge displacement also shifted negatively,
by 8 mV. The parallel shift of flux and voltage sensor
activation is remarkable, as it suggests that the increase
in V m sensitivity of the mutant channel (its activation at a
more negative V m) is not primarily an increase in readiness
of the response to the signals from the V m sensor (as these
appear to be shifted as well, by about the same amount).
An additional outcome of the study is that by +30 mV
the displacement of intramembranous charge is saturated
for both YS and WT cells. Pulses to +30 mV are used in
the remainder of the study.
Cytosolic Ca2+ transients are different in the mutant
A consistent feature distinguishes the time course of
[Ca2+]c in YS mutants. This is illustrated with two
examples in Fig. 1, which compares cytosolic Ca2+ trans-
ients elicited by long duration pulses in a YS cell (panel A)
and a WT cell (B). As shown in earlier work (Royer et al.
2008, 2010) in the WT cells [Ca2+]c continues to rise, more
slowly, after an initial fast phase (black trace in panels C
and D). By contrast, in the YS cells (red trace in C and D)
the second phase is brief, interrupted by a claudication,
marked by an arrow, which usually occurs within the first
100 ms of the pulse. In the time course of flux Ṙ(t), the
claudication corresponds to a ‘dip’ (arrows in panels E
and F). This dip was of variable height and timing, as we
show with these two examples, but was clearly present in
comparisons with WT littermates in every one of 15 YS
cells studied.
As illustrated in Fig. 1G and H , these characteristics
of the YS cells are similarly found in cells exposed to a
large concentration of BAPTA in the cytosol. Records in
G and H are from cells studied previously (Sztretye et al.
2011b), one in internal solution with 5 mM BAPTA, the
other, ‘Reference’, with 10 mM EGTA (this EGTA solution
provides a similar buffering power at equilibrium to
the BAPTA solution, but does not interfere with release
kinetics, due to the much slower rate of Ca2+ binding to
EGTA; Rengifo et al. 2002). The interrupted second rise
in [Ca2+]c in the presence of BAPTA (panel G) is again
associated with an abrupt dip of Ṙ(t) (arrow in panel H).
The statistics of these comparisons are summarized
in Fig. 2A. An expanded summary is presented as
Supplemental Table S1. As shown, there is no difference
between the peak of Ṙ(t) in the YS cells and in its WT
littermates. BAPTA, which increases Ṙ(t) greatly in the WT
(Sztretye et al. 2011b), caused a small and not significant
change in the YS. This is a first example of qualitatively
similar effects of BAPTA and the YS mutation. In this
and other instances, which will be documented later, there
is also mutual ‘occlusion’ of the BAPTA and YS effects.
These effects do not compound quantitatively; when both
BAPTA and the mutation are present, one does not add
much to the effect of the other.
In the mutant [Ca2+]SR is lower and P is higher
Figure 3A shows the FRET ratio of D4cpv-calsequestrin
images simultaneously with the [Ca2+]c record from the
YS cell in Fig. 1A. The traces are an average of three ratio
images, obtained during pulses applied at 3 min intervals.
The line average of this image is plotted in red in Fig. 3B.
The graph includes scales for FRET ratio and [Ca2+]SR.
The initial value of [Ca2+]SR, 200 μM, is much lower
than the example WT, plotted in black (approximately
500 μM). The average resting value of [Ca2+]SR in YS cells
is significantly lower than the WT average (mean ± SEM:
260 ± 54 μm vs. 470 ± 56 μM; Fig. 2B, see also Sztretye
et al. 2011b for earlier measurements in the WT).
Considering that peak flux in the YS is approximately
equal to that in the WT, the lower initial [Ca2+]SR requires
that permeability be increased in the mutant. P(t) for
the example is in Fig. 3C. It peaks higher in the YS, and
remains higher during the pulse, resulting in a greater
relative depletion after a long-lasting depolarization. These
differences are repeated in the averages (Fig. 2C), which
also show that BAPTA greatly increases P in the WT but
not in the YS. Reciprocally, the difference in P observed in
Reference conditions is obliterated in BAPTA (another
example of the occlusion mentioned in the previous
sub-section).
In many YS cells, including the example, P(t) features
a second peak, or ‘hump’. Figure 3D is an average FRET
ratio image from a WT cell in BAPTA. The simultaneously
derived flux, together with [Ca2+]SR(t), in red in Fig. 3E,
are used to derive P(t) (red in panel F). In this and
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other WT cells in BAPTA, a prominent second rise in P
follows the initial peak. Humps in P are a feature common
to YS mutants and WT cells in BAPTA, reinforcing
the notion that the mutation and BAPTA have similar
effects.
An additional feature of [Ca2+]SR(t) in the mutant
is an event that in this example appears as a trans-
ient rise in the concentration (arrows in Fig. 3B and
Supplemental Fig. S1) and in others as an interruption
of the decay (Supplemental Fig. S2). Supplemental
Figure 1. Cytosolic [Ca2+] transient and release flux elicited by maximal depolarization
A and B, normalized line scans of cytosolic dye fluorescence (F(x,t)/F0 (x)) in a YS mutant (A) or a wild-type cell
(B). C, line averages of the arrays in A and B showing a two-stage rise in the WT and an abrupt break during the
2nd stage in the YS (at arrow). Experiment identifiers (ID): YS is 012112b, average of images 39, 40, 43 and 44;
WT is 072309a 43–52. D, line averages in a 2nd example, showing a lesser difference between the YS and its WT
littermate. ID: YS, 042312b 48; WT, 042312d 12. E and F, release flux Ṙ (t) calculated from the records in C and
D, showing a faster decay (arrows) in YS cells. G and H, Ca2+ transients and flux in an EGTA-buffered reference
solution or one with 5 mM BAPTA. The changes introduced by BAPTA are qualitatively similar to those found in
the YS. ID: ‘BAPTA’, 091709a 19; ‘Reference’, 072309a 106.
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Fig. S1 shows line-averaged profiles of the FRET signal
in repeated pulses, to demonstrate reproducibility, with
some variation, in the event features. Figure S2 shows P(t)
with a hump in another cell where [Ca2+]SR(t) interrupts
its decay rather than rising transiently. This example, as
well as the observation of humps in BAPTA, demonstrates
that the secondary rise in P is not necessarily linked with
the anomalous rise that interrupts normal decay in the
temporal evolution of [Ca2+]SR. As one might expect given
the change in driving force for Ca2+, the anomalous rise in
[Ca2+]SR was always accompanied by an increase in release
flux.
SR calcium buffering is altered in the YS mutant
The Ca2+ buffering power, B, of the SR, defined as the
derivative of total SR calcium concentration, [Ca]T,SR, with
respect to free [Ca2+]SR, was derived from ‘buffer plots’ as
illustrated in Fig. 4 for the same YS and WT examples.
This calculation follows closely the description by Manno
et al. (2013). Total amount released, R(t), calculated by
time integration of net flux, is represented in Fig. 4A for
the WT and YS examples of Figs 1 and 3. In Fig. 4C, these
amounts are plotted vs. [Ca2+]SR. Because the cell is a












































Figure 2. Statistical summary of differences
Mean values and SEM for the variables indicated. A, peak release flux, Ṙp, is nearly equal in WT and YS in Reference
solution. BAPTA fails to increase flux in the mutant. ‘(a)’ YS significantly different from WT (P < 0.05). ‘(b)’ WT in
BAPTA significantly different from Reference. B, [Ca2+]SR is lower in the YS at rest, and decreases proportionally
more after maximally depleting pulses. C, peak permeability, derived by dividing Ṙp by [Ca2+]SR at the time of
peak flux, is significantly greater in the YS, but the difference disappears in BAPTA. D, the average buffering power
during the depolarizing pulse, BON, and its value during the OFF, which is approximately equal to the value of
B reached at the end of the pulse, are similar in the WT in Reference. They become different in the YS. BAPTA
increases the difference in the WT, but not in the YS. Cell numbers are listed inside the bars. Data on [Ca2+]SR
were gathered in 7 of 15 YS cells studied in Reference solution, and all 7 YS cells in BAPTA. The WT sets include
cells in a previous study (Manno et al. 2013).
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voltage clamp, and flux into mitochondria and organelles
other than the SR is small (Yi et al. 2011), the change in
total SR calcium is equal to (minus) R(t). Therefore B is
equal to (minus) the slope of the buffer plots. As noted
recently (Manno et al. 2013), B is either constant or slowly
decreasing during a depolarizing pulse in the ‘Reference’,
EGTA-buffered solution. This quasi-linearity is altered in
the YS; in the example (red trace in Fig. 4C) the slope
changes, appearing to go through a very high value (chord




















































































































YS mutant  WT in BAPTA 
Figure 3. The time course of [Ca2+]SR and release permeability
A, FRET ratio of line scan images of fluorescence of D4cpv-calsequestrin in the YS cell whose cytosolic dye line
scan was shown in Fig. 1A. The panel is an average of 3 individual ratio images, scanned during the same pulses
eliciting the records in Fig. 1B, line average of ratio in A. [Ca2+]SR calibration is given on the right side. A brief
increase in [Ca2+]SR (arrow) was observed in repeated pulses. C, P(t), ratio of Ṙ (t) from Fig. 1E and [Ca2+]SR(t)
from this figure, panel B. P is greater in the YS (red trace) and exhibits a hump after the initial peak. Cytosolic F/F0
simultaneously recorded in the YS cell is plotted in grey. The break in the 2nd rise of F/F0 (arrow) coincides with
the trailing side of the hump in P. D, average of 10 line scan ratio images from a WT cell in BAPTA. ID: 051209b
34–43. E, line average of the image in D (red). The curve in black is from the WT in Reference (panel B). F, P(t),
calculated as in C. A second rise in P(t) is a common observation in BAPTA. Note different scales in C and F.
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of high B value corresponds in time to the hump in P (red
trace in Fig. 3C), and the positive slope corresponds with
the brief rise in [Ca2+]SR that interrupts its decay (arrow
in Fig. 3B).
In the presence of BAPTA, B changes markedly during
a depleting pulse (Manno et al. 2013). Buffering data from
the cell in BAPTA illustrated in Fig. 3 are included in
Fig. 4B and D. The main effect of the presence of BAPTA
is the occurrence of a substantial change – a reduction – in
B during the pulse (red trace in Fig. 4D). The slope of the
buffer plot starts high (chord a–a) but decays during the
pulse, ending at a substantially lower value (b–b). The YS
example of Fig. 4C does not show a comparable difference
between initial and final B; instead, it has a large increase
in B roughly mid-way through the pulse, followed by
pronounced decay. On average over all YS cells studied,
there is a clear and significant decay in B during the
pulses (Fig. 2D). In summary, B in the YS in the Reference
solution decreased during a depleting depolarization, a
change that did not happen in the WT. Again, the pre-
sence of BAPTA occluded this difference, as the decay in B





















































































Figure 4. Dynamic Ca2+ buffering in the SR
Continuing analysis of the experiments in Fig. 3. A, amount released R(t), calculated by time integration of net flux.
B, R(t) for the cell in BAPTA illustrated in Fig. 3 (red). In A and B the amount released in the WT cell in Reference
solution is shown in black. C and D, ‘buffer plots’, R(t) vs. [Ca2+]SR(t). Buffering power B (the (minus) slope) is
nearly constant in WT cells in Reference (black), but decays during the pulse in the presence of BAPTA (compare
a–a and b–b). In the YS B changes during the ON, the slope becomes infinite (line d–d) or even changes sign. The
OFF portion of the plot is generally linear. Its (minus) slope, BOFF, is used as an estimate of the value of B at
the end of a pulse (Manno et al. 2013). A difference between the averages BON and BOFF is a measure of the
change in B(t) during the pulse.
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Silencing of the calsequestrin gene replicates
alterations observed in YS cells
The key observation of the present work is that P
increases greatly in the YS cells, reflecting an increase in
channel openness that is probably the main primary defect
associated with the mutation. Breaks in [Ca2+]c(t) and
changes in B can be explained using the known positive
correlation between binding power of calsequestrin and
[Ca2+]SR level (Park et al. 2004; Pape et al. 2007; Manno
et al. 2013). Increased P results in release flux that is large
initially but decays rapidly, as it reduces an already low
SR load. The diminishing binding ability of calsequestrin
feeds back negatively, precipitating the decay of
flux.
To put this idea to the test we used an alternative way
to diminish buffering by calsequestrin: we reduced the
amount of protein. Muscle of adult mice was transfected
with siRNA tested for its ability to silence Casq1 (Wang
et al. 2006). To increase the silencing effect we applied the
vector twice, in both hind paws, with an interval of 5 days.
Mice were studied 4–5 days after the second application.
The FDB of one paw was used for immunoblots and the
other for functional studies of dissociated cells. Figure 5A
shows anti-calsequestrin 1 blots of whole FDB muscles
from four treated and four reference mock-transfected
mice. The measured reduction ranges from 40% to 100%
of reference. We assume, therefore, that in individual cells
treated the same way, silencing was in the same range. As an
additional predictor of silencing, the plasmid vector that
carried the silencer had cDNA for a fluorescent marker:
ECFP for the first injection and EYFP for the second one.
The image panels in Fig. 5 are fluorescence image pairs
of a fibre that expressed only ECFP (panels B) or EYFP
(C), while panels D show a fibre with expression of both
markers. Fibres were not studied functionally unless they
had both markers. This allows certainty that the cells tested
had been transfected with the silencing vector but their
exact degree of reduction in Casq1 was not determined.
It should be noted, though, that the range of 40– 100%
reduction observed with whole muscles is sure to under-
estimate the degree of reduction in individual cells known
to have taken shRNA vector in both injections.
Figure 6A–D compares the [Ca2+]c transients in a
reference cell, a cell from a calsequestrin-null mouse (both
taken from a study of Royer et al. 2010) and a silenced cell.
The Ca2+ transient in the silenced cell (green trace in
Fig. 6D) shows a claudication similar to that in the YS (red
trace in Fig. 1A and C), which interrupts the 2nd rising
phase observed in the WT cell (blue trace in Fig. 6D). This
2nd rise is absent in the Casq-null example (red trace in
Fig. 6D) and in all null cells in the earlier study (Royer
et al. 2010).
In Fig. 6E–G the transient in a second silenced cell,
from a different mouse, is compared with a Ca2+ trans-
ient imaged in a YS cell (Fig. 6F). The similarity in the
kinetic evolution of both records is striking (Fig. 6G).
Both feature a peak, about 100 ms into the pulse, which
reflects an abrupt decay in release flux. As was the case for
mutant cells, abrupt changes in the Ca2+ transients were
not present in all cases, they were observed in 5 of 15 cells
from four silenced muscles (4 animals). The distribution
of intramembranous charge movement was recorded in all
cases and did not change significantly in the silenced cells
Figure 5. Silencing of the Casq1 gene
A, calsequestrin 1 levels in silenced muscles. Blots of 4 reference,
mock-transfected FDB muscles (lanes 1, 2, 7 and 8) or 4
Casq1-silenced muscles, transfected twice with differently marked
shRNA coding vectors as described in the text (lanes 3–6). GAPDH
staining was used as control for protein loading. The extent of Casq1
knock-down varied between 40% (lane 6) and 100% (lane 4). B–D,
fluorescence of transfection markers EYFP (a) or ECFP (b) in three
cells from a muscle treated by two injections of differently marked
silencer. Only the fibre in D showed evidence of transfection by both
applications of silencer.
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(Supplemental Table S3). The observed breaks in the Ca2+
transients were not the consequence of failure of voltage
clamp, as there was no indication of any such failure in the
records of membrane current.
The anomalous buffering properties of YS muscle
fibres are not due to a change in Casq content
The functional similarities, in time course of calcium
transients and altered buffering properties, of YS mutant
myofibres and cells with calsequestrin content made lower
by gene silencing, suggest the reduction of calsequestrin
content as a possible explanation for the changes in the
YS. Calsequestrin content was compared between WT and
YS separately in three types of muscles (EDL, soleus and
diaphragm). The measurements are documented in Fig. 7,
which shows, at the top, representative Western blots and at
the bottom the average densities in muscles of six WT and
six YS. No significant differences in calsequestrin content
between WT and YS mice were found in any of these
muscles.
Discussion
[Ca2+]SR is greatly reduced in the YS mutant
We applied newly available measurements to characterize
functionally adult murine skeletal muscle cells with the
mutation Y524S in their RyR1 channel (corresponding to
Y522S in humans). A first finding was that the resting SR
[Ca2+] is much lower, 260 μM on average (SEM 54 μM),
vs. 470 μM (56 μM) in the WT. This first direct measure of
[Ca2+]SR in a MH muscle serves to explain the increase
in [Ca2+]c observed in the YS (Durham et al. 2008;
Andronache et al. 2009) and other MH models since López
et al. (1986). Indeed, the Cell Boundary Theorem (Rı́os,
2010; Friel & Tsien, 1992) requires that a steady increase
in cytosolic [Ca2+] be justified by changes at the plasma
membrane. Steady SR depletion is expected to activate
store-operated Ca2+ entry, thus increasing [Ca2+]c.
Previous measures of Ca2+ releasable in YS cells by
various stimuli gave a range of results. In YS knock-in mice
there was no change in the amount releasable by caffeine


















































Figure 6. The Ca2+ transients of Casq1-silenced cells
A and B, normalized line scans of cytosolic X-rhod 1 in a reference and a Casq1- and Casq2-null cell (reproduced
from Royer et al. 2010). C, line scan in a doubly transfected cell that was positive for both markers. ID: 102208a17.
D, line averages from images A–C. Note a secondary rise in the silenced cell (similar to that of the WT), which is
interrupted by a rapid decay or break, at ∼100 ms into the depolarization. A similar decay phase, but faster and
earlier, is observed in the Casq-null (red). E, line scan from another cell positive for two silencer applications. ID:
092208b 18. F, line scan of X-rhod 1 in the YS (same cell as in Fig. 1A, but 0.4 s pulses used instead). G, line
averages of images E and F. Note the agreement in time course, including a secondary rise ended by a break,
∼100 ms into the pulse.
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depolarization (Andronache et al. 2009). RyR-null myo-
tubes transiently expressing the YS RyR1 showed a major
decrease in release by caffeine (Avila & Dirksen, 2001).
The present results help clarify the variability by showing
both a major reduction in the directly measured resting
[Ca2+]SR and an increase in the depletion achievable by
depolarization. According to the present set of results
these changes tend to compensate, resulting in similar
releasable amounts in mutant and WT cells. Different
conditions, including changes in temperature (Durham
et al. 2008), may alter these features differently, explaining
the variability in previous reports.
The permeability to Ca2+ of the SR membrane is
greatly increased in the mutant
The measurement of [Ca2+]SR made possible for the
first time in YS cells the direct calculation of release
permeability, P (eqn (3)). Peak P, compared in Fig. 2A,
was substantially increased in the YS by about the same
ratio as that in which resting [Ca2+]SR was decreased,
resulting in approximately equal average values of peak
flux. P(t) remained greater in the YS during the pulse,
leading to a greater degree of depletion. While in the WT
[Ca2+]SR stabilized at 150–200 μM during a long-lasting






























Figure 7. Calsequestrin content of wild-type and Y522S
mutant muscles
Top, Western blot images from three muscles in one wild-type (WT)
and one mutant mouse (YS). Bottom, mean values and SEM for six
muscles of each type and mouse strain of the optical density
normalized by the GAPDH value in the same muscle. The differences
between WT and YS were not significant in any case.
depletion was on average 80 μM. This increase in P plus
the changes in resting [Ca2+]SR and releasable fraction
combine to explain the well-documented conservation of
a stable basal function in spite of the major reduction in
SR load.
The situation in the YS mutant appears similar to that in
mice with R163C, another MH-linked mutation in RyR1
(Yang et al. 2006). Indeed [Ca2+]c is elevated at rest in RC
myotubes and adult fibres (Feng et al. 2011). While no
direct measurement is available, an increase in [Ca2+]c
is usually accompanied (and probably determined) by
a decrease in [Ca2+]SR (e.g. Eltit et al. 2013). In spite
of the probable reduction in [Ca2+]SR, the Ca2+ trans-
ients in response to electrical stimulation are similar
(Feng et al. 2011), which in turn requires increased P.
This ‘compensated deficit’ in SR load thus emerges as a
motif, common to RyR mutations that determine MH
susceptibility via gain of RyR channel function.
As is true in the WT, the decay or ‘termination’ of
release flux in the YS mutant results from SR depletion and
channel closing. The combination in the YS of increased
P and low starting SR load led to a Ṙ(t) that decayed
rapidly. The altered Ṙ(t) resulted in a Ca2+ transient
of characteristic shape, which instead of the second rise
visible in the WT cells displayed a decaying phase that
could be sharp.
In the same strain of mice it has been shown
that the activation of flux is shifted to lower V m by
about 8 mV while the activation of the membrane
voltage sensor (as reflected in the V m dependence of
intramembranous charge movement) is equally shifted
(Andronache et al. 2009). Impressed by this observation,
we confirmed that the shifts are similar (Supplemental
Tables S1 and S2). The result implies that the intrinsic
sensitivity of the channel to signals from the V m sensor
is not changed detectably, an intriguing conclusion
given that the mutation undoubtedly shifts the channels
towards the open state. This conundrum is addressed
later.
The mutant may have reduced Ca2+-dependent
inactivation of the RyR
A striking aspect of the observed effects of the mutation
is their similarity with those of BAPTA. Indeed, in 5 mM
cytosolic BAPTA peak P increased greatly in the WT, to
values similar to those of the YS in Reference conditions,
while the presence of BAPTA abolished the difference
in P between YS and WT (Fig. 2C). The mutation and
BAPTA mutually occlude rather than compound their
effects, an indication that they increase channel openness
by similar mechanisms. The agreement of the effects on P
is not limited to its peak; a similar hump in P(t) can be
found in YS cells in Reference and WT cells in BAPTA
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(Fig. 3C and F). Finally, BAPTA and the YS mutation
caused similar alterations in SR Ca2+ buffering.
BAPTA has an ON rate constant 100 times greater
than that of EGTA (Wu et al. 1996). At the concentration
used in our Reference solution EGTA does not alter the
normal gating of the RyR1 (Rengifo et al. 2002; González
& Rı́os, 1993). Inclusion of fast reacting Ca2+ ligands such
as Fura-2 (Baylor & Hollingworth, 1988) or BAPTA at
concentrations as low as 0.3 mM (Posterino & Lamb, 2003)
is believed to promote flux by obstructing Ca2+-dependent
inactivation of RyR1. It is therefore possible that one of the
primary effects of the YS mutation is to interfere with CDI.
The alternative, that mutation and BAPTA increase P by
different mechanisms and the increased P then determines
other effects that agree qualitatively and quantitatively,
seems less plausible.
The Ca2+ binding sites involved in CDI are thought
to face the cytosol (Fill & Copello, 2002). Their location
is placed close to the cytosolic pore opening by evidence
of involvement of the permeating ions in the inhibition
process (the so-called ‘feed-through’ mechanism; Jong
et al. 1993; Tripathy & Meissner, 1996; Pape et al. 1998;
Pizarro & Rı́os, 2004).
The location of tyrosines 522 in the RyR1 tetramer
is established with precision. They are in domain C of
hotspot 1, at the far end of the domain relative to the
centre of the tetramer, in a cytosolic vestibule 7–8 nm away
from the pore (Tung et al. 2010). While none of the critical
residues in this hotspot appear to be actually exposed to the
cytosol, Y522 is very close to it. Replacement of a tyrosine
in this location may alter a Ca2+ binding site near the pore
exit or modify the allosteric consequences of Ca2+ binding
nearby.
The reason for the shift in V m dependence of the
voltage sensor must be found in its link with the channel.
Indeed, facilitation of channel opening, by chaotropic
anions (González & Rı́os, 1993) or the modulatory protein
S100A1 (Prosser et al. 2009), enhances the movement of
the voltage sensor in a feedback loop mediated by released
Ca2+ and/or allosteric connections (Csernoch et al. 1991;
Rı́os et al. 1993; Prosser et al. 2009).
Some differences between the effects of the mutation
and BAPTA must be noted. While the mutation shifted the
movement of the V m sensor to lower voltages, BAPTA did
not. Additionally, the mutation reduced resting [Ca2+]SR
more than 5 mM BAPTA (Fig. 2B). These differences may
reflect additional ways in which the mutation and BAPTA
modify channel function.
Ca2+ buffering ability in the YS mutant
The alterations in B, the Ca2+ buffering power of the SR
in the YS, recapitulate the dynamic changes reported in
BAPTA (Manno et al. 2013): B starts high and decreases
during a long-lasting depolarization. Fast loss of buffering
power during a depolarization coincides temporally with
the characteristic break observed in the Ca2+ transients
and release flux (Fig. 1A, C and E).
Ca2+ buffering in the SR is largely the role of
calsequestrin (e.g. Murphy et al. 2009; Manno et al. 2013).
How could a change in B, and by inference a functional
change in calsequestrin, result from the primary functional
alteration in the mutant – an increase in P? And how can
this happen without changes in Casq content?
A possible answer is illustrated with the schematic
diagram in Fig. 8. The proposal is based on evidence
that calsequestrin changes conformation as it binds Ca2+
in vitro (e.g. Mitchell et al. 1988), a change later shown
by Park et al. 2003, 2004) to correspond to linear poly-
merization, and recently demonstrated to require Ca2+
ions at interfaces formed when the protein polymerizes
(Sánchez et al. 2012). The figure depicts a linear ramified
polymeric calsequestrin network, stabilized by Ca2+ (red
dots), and reflects the consensual role of triadin, linking
calsequestrin to the RyR (reviewed by Marty et al. 2009).
The stoichiometric anchoring of calsequestrin polymers
near RyR channel openings is based on electron micro-
scopic images by Boncompagni et al. (2012). Figure 8A
corresponds to the initial situation in the WT as channels
open, with [Ca2+]SR at its resting level. As release proceeds
Ca2+ ions leave calsequestrin, which results in a less
stable network, depicted in panel B as having a somewhat
distorted structure. According to the Ca2+-binding curves
of the protein in solution (e.g. Park et al. 2004), this
moderately depleted situation results in a lowering of
buffering capacity and power.
Pape et al. (2007), working with frog muscle, were
the first to demonstrate a decay of buffering power with
progressive depletion in functioning SR. Manno et al.
(2013) confirmed the observation in mammalian muscle
but noted that the change in B with depletion only became
significant in the presence of cytosolic BAPTA, which
together with other aspects of the observation indicated
that a fast rate of Ca2+ release was required to induce the
change in B. A faster flux will produce greater luminal
[Ca2+] gradients, and locally more pronounced and more
spatially heterogeneous loss of Ca2+ from the calsequestrin
network. The spatial heterogeneity is likely to destabilize
the network further, enhancing the loss of binding sites.
If the reduction in free [Ca2+]SR and the loss of bound
Ca2+ are sufficiently rapid, the calsequestrin network
might collapse, i.e. undergo a large-scale change in
structure, pictured in Fig. 8C. This would result in the
sudden disappearance of a large set of Ca2+ binding sites,
with the consequent passage of bound Ca2+ to free solution
(a luminal Ca2+ transient). This mechanism was proposed
to explain calsequestrin-dependent transient increases in
luminal [Ca2+] since they were first observed in vesicular
preparations (Ikemoto et al. 1991) and also when found
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Figure 8. Imagining Ca2+-dependent states of the
calsequestrin network
A, situation at the start of a Ca2+ release event. The RyR channel
(blue) has just opened. At the resting concentration, Ca2+ in the SR
(red) cross-links calsequestrin protomers into a stable polymeric
network. Triadin (green) links the RyR to calsequestrin and provides
anchors for the network. B, the situation after Ca2+ release. Partial
depletion results in lower free and bound [Ca2+], which destabilizes
the network, partially altering its structure, causing loss of Ca2+
coordination sites and leading to a reduced Ca2+ buffering power B.
Manno et al. (2013) have shown that a high rate of Ca2+ release is
an adjuvant to the loss of B. C, a situation of widespread collapse of
in frog skeletal muscle (Launikonis et al. 2006). While
such luminal Ca2+ transients have been observed under
a number of stimuli, they are not the rule in mammalian
muscle, as shown by the present measurements in the
wild-type, and in recent work by various laboratories
(Sztretye et al. 2011b; Canato et al. 2011; Wang et al.
2012), which found that the decay of [Ca2+]SR was
monotonic.
Luminal Ca2+ transients are found again here, this
time in YS mutants. Similar to the observations of
Launikonis et al. (2006), the luminal transients in the YS
are accompanied by a characteristic feature in the cytosolic
Ca2+ transient: a sudden rise, with a sharp termination, not
associated with any change in plasma membrane current.
Surprisingly, cytosolic Ca2+ transients with essentially the
same characteristics were found in adult fibres with acute
silencing of the Casq1 gene, causing severe but incomplete
reduction in the protein endowment. It is likely that
these sharp cytosolic events reflect similar luminal Ca2+
increases.
At first sight, the circumstances in YS mutant and
Casq1-silenced cells would seem to be very different. Most
importantly, and as shown with Fig. 7, the calsequestrin
content of the YS mutant cells is not reduced as it is in
the Casq1-silenced myofibres. They, however, share one
condition, a disproportion between P, which is normal in
the silenced cell and enhanced in the mutant, and B, which
is greatly reduced in the silenced cell, as well as in the YS
by virtue of the lower resting [Ca2+]SR.
We therefore propose that the unusual Ca2+ transients
observed in the YS mutant and the Casq1-silenced cells
have as shared cause a collapse of the large-scale polymeric
network of calsequestrin due in turn to the imbalance
between the ability to release Ca2+ and extant SR Ca2+
buffering power. That these transients remain infrequent
is consistent with the lack of electron microscopic evidence
of major changes in the SR luminal structures after
depleting interventions (C. Franzini-Armstrong, personal
communication).
The pathogenesis of an MH event
An emerging consensus associates MH susceptibility to
‘gain of function’ mutations in RyR1, which increase
the channel’s tendency to open and/or delay its closure
the polymeric network, which leads to large-scale loss of
coordination sites and passage of large amounts of the ion to free
solution, is proposed to explain the transient increase in [Ca2+]SR
observed here in the YS. The increased P associated with the
mutation allows for an initial flux of normal magnitude, which will
very rapidly deplete an SR that starts with low Ca2+ content and low
B. See further discussion in the text.
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(Dirksen & Avila, 2004; Avila, 2005). Although the details
of the pathogenesis of the MH events are poorly under-
stood, an MH event is characterized by uncontrolled Ca2+
release (reviewed by Melzer et al. 1995). The present results
indicate that a failure of CDI may contribute to the MH
response in the YS model.
The Y522S mutation is associated with MH with central
cores (Chelu et al. 2006). A pressing question about
the pathogenesis of inheritable RyR1 diseases is why
cores associate with some, but not all, MH-inducing
mutations. Cores may reflect the damaging effects of
chronically elevated local [Ca2+]c (e.g. Lamb & Cellini,
1999; MacLennan & Zvaritch, 2011) and/or increased
oxidative/nitrosative stress by reactive oxygen and nitrogen
species (Durham et al. 2008; Lanner et al. 2012). The YS
mice appear to be the most sensitive of the current mouse
models of MH to heat and also appear to show severe
Ca2+ store depletion (present results) which is strongly
temperature dependent (Durham et al. 2008; Lanner et al.
2012). Sustained changes associated with the YS mutation
(temperature-dependent increases in cytosolic calcium,
decreased [Ca2+]SR and resulting conformational changes
in calsequestrin and triadin) may alter, directly or via inter-
actions with the SR, interfibrillar mitochondrial function,
and activate proteolytic enzymes to a greater extent in the
YS mice than in other mouse MH models, leading to the
formation of cores. Further studies and comparisons of
the current mouse models of MH without cores, MH with
cores and CCD without MH are needed to fully elucidate
mechanisms of core formation. Particularly challenging
will be the elucidation of the mechanisms whereby MH
mutations that increase Ca2+ leak and the CCD mutations
that partially decrease Ca2+ efflux both produce central
cores and are associated with impaired muscle function in
humans.
Diseases of the couplon
The present work has general consequences regarding the
diseases that affect Ca2+ release in striated muscles. As
stated before, not just mutations in RyR2 but several in
calsequestrin 2 (Priori & Chen, 2011) and at least one in
triadin (Roux-Buisson et al. 2012) are linked with CPVT.
Extending the cardiac–skeletal parallel, MH-like events
have been demonstrated in mice devoid of calsequestrin
(Protasi et al. 2011). These associations suggest the
operation of a common pathogenetic pathway whereby
similar phenotypes arise from defects, not only in different
locations within the RyR, but also in different members
of the chain of proteins, the couplon, that control Ca2+
release. The striking parallel demonstrated in the present
work between the changes in Ca2+ signalling induced by
the Y522S mutation in the RyR1 and the knock-down of
calsequestrin 1, supports the existence of couplon-wide
noxogenic aetiologies whose mechanisms remain to be
established in detail.
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